Structure

(3aR,7aR)-4'-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1'-piperazinium] methanesulfonate

CAS
186204-37-5
Catalog Number
ACM186204375
Category
Other Products
Molecular Weight
422.564740 [g/mol]
Molecular Formula
C19H26N4O3S2

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
186204-37-5, 4-(Benzo[d]isothiazol-3-yl)-1-((3aR,7aR)-hexahydro-1H-isoindol-2(3H)-yl)piperazin-1-ium-1-sulfonate, SCHEMBL2540360, AKOS024462922, AK160912, ST24043013
IUPAC Name
1-[(3aR,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-4-(1,2-benzothiazol-3-yl)piperazin-1-ium-1-sulfonate
SMILES
C1CCC2CN(CC2C1)[N+]3(CCN(CC3)C4=NSC5=CC=CC=C54)S(=O)(=O)[O-]
InChI Key
FKKBEEHBJWWXMP-HOTGVXAUSA-N
Exact Mass
422.14500
H-Bond Acceptor
7
H-Bond Donor
0

Upstream Synthesis Route 1

  • 186204-35-3
  • 87691-87-0
  • 186204-37-5

Reference: [1]Patent: WO2015/56205,2015,A1 .Location in patent: Page/Page column 14

Downstream Synthesis Route 1

  • 186204-37-5
  • 14805-29-9
  • 367514-88-3

Reference: [1] Patent: WO2015/56205, 2015, A1, . Location in patent: Page/Page column 14

Downstream Synthesis Route 2

  • 186204-37-5
  • 1074-82-4
  • 1260025-92-0

Reference: [1]Current Patent Assignee: Sumitomo Chemical (w/o Dongwoo Fine-Chem); Sumitomo Pharma (in: Sumitomo Chemical); SUMITOMO CHEMICAL COMPANY LIMITED - US2011/3994, 2011, A1
Location in patent: Page/Page column 6-7

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.